Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.

IDE activators with desirable pharmacokinetic properties may be significant for diabetes, as it is questionable to combat with diabetes or hyperinsulinemia through genetic mutations of IDE gene [28] .

also in 13,097 other papers